Literature DB >> 19465826

Repeat pregnancies among HIV-infected women enrolled in clinical trial PACTG1022.

D Heather Watts, Sharon Huang, Susan E Cohn, Laura Smith, Jane Hitti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19465826      PMCID： PMC2766524          DOI： 10.1097/QAI.0b013e3181a5b053

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  10 in total

1.  Contraception and prevention of HIV infection.

Authors:  Willard Cates
Journal:  JAMA       Date:  2006-12-20       Impact factor: 56.272

2.  Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.

Authors:  S E Cohn; J-G Park; D H Watts; A Stek; J Hitti; P A Clax; S Yu; J J L Lertora
Journal:  Clin Pharmacol Ther       Date:  2006-12-27       Impact factor: 6.875

3.  Incident pregnancy rates in HIV infected and HIV uninfected at-risk adolescents.

Authors:  L Levin; L Henry-Reid; D A Murphy; L Peralta; M Sarr; Y Ma; A S Rogers
Journal:  J Adolesc Health       Date:  2001-09       Impact factor: 5.012

4.  Pregnancies before and after HIV diagnosis in a european cohort of HIV-infected women. European Study on the Natural History of HIV Infection in Women.

Authors:  B H van Benthem; I de Vincenzi; M C Delmas; C Larsen; A van den Hoek; M Prins
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

5.  Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV.

Authors:  L Stewart Massad; Gayle Springer; Lisa Jacobson; Heather Watts; Kathryn Anastos; Abner Korn; Helen Cejtin; Alice Stek; Mary Young; Julie Schmidt; Howard Minkoff
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

6.  Trends in pregnancy rates among women with human immunodeficiency virus.

Authors:  Janet M Blair; Debra L Hanson; Jeffrey L Jones; Mark S Dworkin
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

7.  Complications of use of intrauterine devices among HIV-1-infected women.

Authors:  S K Sinei; C S Morrison; C Sekadde-Kigondu; M Allen; D Kokonya
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

8.  Contraception and fertility plans in a cohort of HIV-positive women in care.

Authors:  Nancy L Stanwood; Susan E Cohn; Jennifer R Heiser; MaryAnn Pugliese
Journal:  Contraception       Date:  2007-02-22       Impact factor: 3.375

9.  A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.

Authors:  Elizabeth M Stringer; Christine Kaseba; Jens Levy; Moses Sinkala; Robert L Goldenberg; Benjamin H Chi; Inutu Matongo; Sten H Vermund; Mulindi Mwanahamuntu; Jeffrey S A Stringer
Journal:  Am J Obstet Gynecol       Date:  2007-08       Impact factor: 8.661

10.  Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

Authors:  Jane Hitti; Lisa M Frenkel; Alice M Stek; Sharon A Nachman; David Baker; Adolfo Gonzalez-Garcia; Arthur Provisor; Edwin M Thorpe; Mary E Paul; Marc Foca; Jorge Gandia; Sharon Huang; Lee-Jen Wei; Laura M Stevens; D Heather Watts; James McNamara
Journal:  J Acquir Immune Defic Syndr       Date:  2004-07-01       Impact factor: 3.731
  10 in total
  2 in total

1.  Repeat pregnancy in women with HIV infection in Latin America and the Caribbean.

Authors:  Regis Kreitchmann; Karen Megazzini; Victor Hugo Melo; Débora Fernandes Coelho; D Heather Watts; Margot Krauss; Maria Isabel Gouvea; Geraldo Duarte; Marcelo H Losso; George K Siberry
Journal:  AIDS Care       Date:  2015-08-19

2.  Reduced HIV transmission at subsequent pregnancy in a resource-poor setting.

Authors:  Felicity Zvanyadza Gumbo; Gwendoline Quintoline Kandawasvika; Kerina Duri; Munyaradzi Paul Mapingure; Nyaradzai Edith Kurewa; Kusum Nathoo; Simbarashe Rusakaniko; Mike Zvavahera Chirenje; Babill Stray-Pedersen
Journal:  Trop Doct       Date:  2011-05-16       Impact factor: 0.731
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.